Loading…
Association between depression and HIV treatment outcomes in a US military population with HIV infection
Depression is common among HIV-infected individuals and may contribute to suboptimal adherence to antiretroviral therapy (ART) and subsequent inability to attain viral load (VL) suppression. We evaluated associations between depression, self-reported adherence, and longitudinal HIV treatment outcome...
Saved in:
| Published in: | AIDS research and therapy 2021-05, Vol.18 (1), p.29-29, Article 29 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c628t-b8bb96242e25f93540a6e9c182a6bef5e31efc8f4b568ebe28f361ab80119a3f3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c628t-b8bb96242e25f93540a6e9c182a6bef5e31efc8f4b568ebe28f361ab80119a3f3 |
| container_end_page | 29 |
| container_issue | 1 |
| container_start_page | 29 |
| container_title | AIDS research and therapy |
| container_volume | 18 |
| creator | Carney, Brandon Daniels, Colton Xu, Xiaohe Sunil, Thankam Ganesan, Anuradha Blaylock, Jason M Kronmann, Karl C Schofield, Christina Lalani, Tahaniyat Agan, Brian Okulicz, Jason F |
| description | Depression is common among HIV-infected individuals and may contribute to suboptimal adherence to antiretroviral therapy (ART) and subsequent inability to attain viral load (VL) suppression. We evaluated associations between depression, self-reported adherence, and longitudinal HIV treatment outcomes in US Military HIV Natural History Study (NHS) participants with and without depression.
Male NHS participants with available ICD-9 data for mental health diagnoses, Center for Epidemiological Studies Depression (CES-D) measures, and self-reported adherence (SRA) were included. ART use was defined as ART initiation between 2006 and 2010, with follow-up through 2015. SRA was defined as taking 95% of ART doses and continuous ART was defined as longitudinal ART use with gaps |
| doi_str_mv | 10.1186/s12981-021-00350-2 |
| format | article |
| fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0ace82e1f04e42fcb4f46e36231ca2fe</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A665429874</galeid><doaj_id>oai_doaj_org_article_0ace82e1f04e42fcb4f46e36231ca2fe</doaj_id><sourcerecordid>A665429874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c628t-b8bb96242e25f93540a6e9c182a6bef5e31efc8f4b568ebe28f361ab80119a3f3</originalsourceid><addsrcrecordid>eNptkl2L1DAYhYso7rr6B7yQgiB60TVfzaQ3wrCoO7igoOttSNM30wxtM5ukrv570-m6TkVKaXjznNPm9GTZc4zOMRb8bcCkErhAJN2IlqggD7JTvGKk4AyVD4_WJ9mTEHYJ4gSXj7MTSiuBCCenWbsOwWmronVDXkO8BRjyBvYeQphGamjyy833PHpQsYch5m6M2vUQcpt28-uveW87G5X_le_dfuxmp1sb24PODgb0NHqaPTKqC_Ds7nmWXX94_-3isrj6_HFzsb4qNCciFrWo64oTRoCUpqIlQ4pDpbEgitdgSqAYjBaG1SUXUAMRhnKsaoEwrhQ19CzbzL6NUzu597ZPnyadsvIwcH4rlY9WdyCR0iAIYIMYMGJ0zQzjkDKiWCtiIHm9m732Y91Do9PxveoWpsudwbZy635IgfGKCJoMXt8ZeHczQoiyt0FD16kB3BgkKQmnGGFRJvTlP-jOjX5IUU2UEBUXmP-ltiodIIXr0nv1ZCrXnJcsFWLFEnX-HypdDfRWuwGMTfOF4M1CkJgIP-NWjSHIT182S_bVEduC6mIbXDdOPzksQTKD2rsQPJj74DCSU4HlXGCZCiwPBZYkiV4cR34v-dNY-hto4en0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2528896816</pqid></control><display><type>article</type><title>Association between depression and HIV treatment outcomes in a US military population with HIV infection</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Carney, Brandon ; Daniels, Colton ; Xu, Xiaohe ; Sunil, Thankam ; Ganesan, Anuradha ; Blaylock, Jason M ; Kronmann, Karl C ; Schofield, Christina ; Lalani, Tahaniyat ; Agan, Brian ; Okulicz, Jason F</creator><creatorcontrib>Carney, Brandon ; Daniels, Colton ; Xu, Xiaohe ; Sunil, Thankam ; Ganesan, Anuradha ; Blaylock, Jason M ; Kronmann, Karl C ; Schofield, Christina ; Lalani, Tahaniyat ; Agan, Brian ; Okulicz, Jason F</creatorcontrib><description>Depression is common among HIV-infected individuals and may contribute to suboptimal adherence to antiretroviral therapy (ART) and subsequent inability to attain viral load (VL) suppression. We evaluated associations between depression, self-reported adherence, and longitudinal HIV treatment outcomes in US Military HIV Natural History Study (NHS) participants with and without depression.
Male NHS participants with available ICD-9 data for mental health diagnoses, Center for Epidemiological Studies Depression (CES-D) measures, and self-reported adherence (SRA) were included. ART use was defined as ART initiation between 2006 and 2010, with follow-up through 2015. SRA was defined as taking 95% of ART doses and continuous ART was defined as longitudinal ART use with gaps < 30 days. Continuous VL suppression was defined as maintaining VLs < 200 c/mL on ART. To analyse the association between depression and HIV treatment outcomes, latent class analysis was used to create classes of depression trajectories: low depression (LD), recent onset depression (ROD) and high Depression (HD).
Participants had a mean age of 32 (± 8.3) years at HIV diagnosis, and similar proportions were Caucasian (44.3%) or African American (40.8%). Overall, older participants at HIV diagnosis had greater odds of having 95% self-reported adherence (OR 1.06, 95% CI 1.02-1.12), and African Americans had lower odds (OR 0.41, 95% CI 0.22-0.76) compared to Caucasians (OR 1.49, 95% CI 0.52-4.28). However, there was no difference in SRA by depression trajectory. Participants with HD had an increased odds of taking ART continuously (OR 1.75, 95% CI 0.99-3.09), and those with ROD had significantly higher odds of virologic failure (OR 0.58, 95% CI 0.38-0.91).
Although there was no observed association between depression and SRA, participants with ROD had lower odds of attaining the HIV treatment goal of VL suppression. Continued efforts to identify and aggressively manage mental health disorders is important to success along the HIV care continuum.</description><identifier>ISSN: 1742-6405</identifier><identifier>EISSN: 1742-6405</identifier><identifier>DOI: 10.1186/s12981-021-00350-2</identifier><identifier>PMID: 33980262</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adherence ; African Americans ; Age ; AIDS/HIV ; Antiretroviral agents ; Antiretroviral therapy ; Care and treatment ; Clinical outcomes ; Demographics ; Depression ; Depression, Mental ; Diagnosis ; Epidemiology ; HIV ; HIV infection ; Human immunodeficiency virus ; Mental depression ; Mental disorders ; Mental health ; Minority & ethnic groups ; Psychological aspects ; Short Report ; Viral load suppression</subject><ispartof>AIDS research and therapy, 2021-05, Vol.18 (1), p.29-29, Article 29</ispartof><rights>COPYRIGHT 2021 BioMed Central Ltd.</rights><rights>2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c628t-b8bb96242e25f93540a6e9c182a6bef5e31efc8f4b568ebe28f361ab80119a3f3</citedby><cites>FETCH-LOGICAL-c628t-b8bb96242e25f93540a6e9c182a6bef5e31efc8f4b568ebe28f361ab80119a3f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117283/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2528896816?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33980262$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carney, Brandon</creatorcontrib><creatorcontrib>Daniels, Colton</creatorcontrib><creatorcontrib>Xu, Xiaohe</creatorcontrib><creatorcontrib>Sunil, Thankam</creatorcontrib><creatorcontrib>Ganesan, Anuradha</creatorcontrib><creatorcontrib>Blaylock, Jason M</creatorcontrib><creatorcontrib>Kronmann, Karl C</creatorcontrib><creatorcontrib>Schofield, Christina</creatorcontrib><creatorcontrib>Lalani, Tahaniyat</creatorcontrib><creatorcontrib>Agan, Brian</creatorcontrib><creatorcontrib>Okulicz, Jason F</creatorcontrib><title>Association between depression and HIV treatment outcomes in a US military population with HIV infection</title><title>AIDS research and therapy</title><addtitle>AIDS Res Ther</addtitle><description>Depression is common among HIV-infected individuals and may contribute to suboptimal adherence to antiretroviral therapy (ART) and subsequent inability to attain viral load (VL) suppression. We evaluated associations between depression, self-reported adherence, and longitudinal HIV treatment outcomes in US Military HIV Natural History Study (NHS) participants with and without depression.
Male NHS participants with available ICD-9 data for mental health diagnoses, Center for Epidemiological Studies Depression (CES-D) measures, and self-reported adherence (SRA) were included. ART use was defined as ART initiation between 2006 and 2010, with follow-up through 2015. SRA was defined as taking 95% of ART doses and continuous ART was defined as longitudinal ART use with gaps < 30 days. Continuous VL suppression was defined as maintaining VLs < 200 c/mL on ART. To analyse the association between depression and HIV treatment outcomes, latent class analysis was used to create classes of depression trajectories: low depression (LD), recent onset depression (ROD) and high Depression (HD).
Participants had a mean age of 32 (± 8.3) years at HIV diagnosis, and similar proportions were Caucasian (44.3%) or African American (40.8%). Overall, older participants at HIV diagnosis had greater odds of having 95% self-reported adherence (OR 1.06, 95% CI 1.02-1.12), and African Americans had lower odds (OR 0.41, 95% CI 0.22-0.76) compared to Caucasians (OR 1.49, 95% CI 0.52-4.28). However, there was no difference in SRA by depression trajectory. Participants with HD had an increased odds of taking ART continuously (OR 1.75, 95% CI 0.99-3.09), and those with ROD had significantly higher odds of virologic failure (OR 0.58, 95% CI 0.38-0.91).
Although there was no observed association between depression and SRA, participants with ROD had lower odds of attaining the HIV treatment goal of VL suppression. Continued efforts to identify and aggressively manage mental health disorders is important to success along the HIV care continuum.</description><subject>Adherence</subject><subject>African Americans</subject><subject>Age</subject><subject>AIDS/HIV</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral therapy</subject><subject>Care and treatment</subject><subject>Clinical outcomes</subject><subject>Demographics</subject><subject>Depression</subject><subject>Depression, Mental</subject><subject>Diagnosis</subject><subject>Epidemiology</subject><subject>HIV</subject><subject>HIV infection</subject><subject>Human immunodeficiency virus</subject><subject>Mental depression</subject><subject>Mental disorders</subject><subject>Mental health</subject><subject>Minority & ethnic groups</subject><subject>Psychological aspects</subject><subject>Short Report</subject><subject>Viral load suppression</subject><issn>1742-6405</issn><issn>1742-6405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkl2L1DAYhYso7rr6B7yQgiB60TVfzaQ3wrCoO7igoOttSNM30wxtM5ukrv570-m6TkVKaXjznNPm9GTZc4zOMRb8bcCkErhAJN2IlqggD7JTvGKk4AyVD4_WJ9mTEHYJ4gSXj7MTSiuBCCenWbsOwWmronVDXkO8BRjyBvYeQphGamjyy833PHpQsYch5m6M2vUQcpt28-uveW87G5X_le_dfuxmp1sb24PODgb0NHqaPTKqC_Ds7nmWXX94_-3isrj6_HFzsb4qNCciFrWo64oTRoCUpqIlQ4pDpbEgitdgSqAYjBaG1SUXUAMRhnKsaoEwrhQ19CzbzL6NUzu597ZPnyadsvIwcH4rlY9WdyCR0iAIYIMYMGJ0zQzjkDKiWCtiIHm9m732Y91Do9PxveoWpsudwbZy635IgfGKCJoMXt8ZeHczQoiyt0FD16kB3BgkKQmnGGFRJvTlP-jOjX5IUU2UEBUXmP-ltiodIIXr0nv1ZCrXnJcsFWLFEnX-HypdDfRWuwGMTfOF4M1CkJgIP-NWjSHIT182S_bVEduC6mIbXDdOPzksQTKD2rsQPJj74DCSU4HlXGCZCiwPBZYkiV4cR34v-dNY-hto4en0</recordid><startdate>20210512</startdate><enddate>20210512</enddate><creator>Carney, Brandon</creator><creator>Daniels, Colton</creator><creator>Xu, Xiaohe</creator><creator>Sunil, Thankam</creator><creator>Ganesan, Anuradha</creator><creator>Blaylock, Jason M</creator><creator>Kronmann, Karl C</creator><creator>Schofield, Christina</creator><creator>Lalani, Tahaniyat</creator><creator>Agan, Brian</creator><creator>Okulicz, Jason F</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>KPI</scope><scope>3V.</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210512</creationdate><title>Association between depression and HIV treatment outcomes in a US military population with HIV infection</title><author>Carney, Brandon ; Daniels, Colton ; Xu, Xiaohe ; Sunil, Thankam ; Ganesan, Anuradha ; Blaylock, Jason M ; Kronmann, Karl C ; Schofield, Christina ; Lalani, Tahaniyat ; Agan, Brian ; Okulicz, Jason F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c628t-b8bb96242e25f93540a6e9c182a6bef5e31efc8f4b568ebe28f361ab80119a3f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adherence</topic><topic>African Americans</topic><topic>Age</topic><topic>AIDS/HIV</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral therapy</topic><topic>Care and treatment</topic><topic>Clinical outcomes</topic><topic>Demographics</topic><topic>Depression</topic><topic>Depression, Mental</topic><topic>Diagnosis</topic><topic>Epidemiology</topic><topic>HIV</topic><topic>HIV infection</topic><topic>Human immunodeficiency virus</topic><topic>Mental depression</topic><topic>Mental disorders</topic><topic>Mental health</topic><topic>Minority & ethnic groups</topic><topic>Psychological aspects</topic><topic>Short Report</topic><topic>Viral load suppression</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carney, Brandon</creatorcontrib><creatorcontrib>Daniels, Colton</creatorcontrib><creatorcontrib>Xu, Xiaohe</creatorcontrib><creatorcontrib>Sunil, Thankam</creatorcontrib><creatorcontrib>Ganesan, Anuradha</creatorcontrib><creatorcontrib>Blaylock, Jason M</creatorcontrib><creatorcontrib>Kronmann, Karl C</creatorcontrib><creatorcontrib>Schofield, Christina</creatorcontrib><creatorcontrib>Lalani, Tahaniyat</creatorcontrib><creatorcontrib>Agan, Brian</creatorcontrib><creatorcontrib>Okulicz, Jason F</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Global Issues database</collection><collection>ProQuest Central (Corporate)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database (Proquest)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>AIDS research and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carney, Brandon</au><au>Daniels, Colton</au><au>Xu, Xiaohe</au><au>Sunil, Thankam</au><au>Ganesan, Anuradha</au><au>Blaylock, Jason M</au><au>Kronmann, Karl C</au><au>Schofield, Christina</au><au>Lalani, Tahaniyat</au><au>Agan, Brian</au><au>Okulicz, Jason F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association between depression and HIV treatment outcomes in a US military population with HIV infection</atitle><jtitle>AIDS research and therapy</jtitle><addtitle>AIDS Res Ther</addtitle><date>2021-05-12</date><risdate>2021</risdate><volume>18</volume><issue>1</issue><spage>29</spage><epage>29</epage><pages>29-29</pages><artnum>29</artnum><issn>1742-6405</issn><eissn>1742-6405</eissn><abstract>Depression is common among HIV-infected individuals and may contribute to suboptimal adherence to antiretroviral therapy (ART) and subsequent inability to attain viral load (VL) suppression. We evaluated associations between depression, self-reported adherence, and longitudinal HIV treatment outcomes in US Military HIV Natural History Study (NHS) participants with and without depression.
Male NHS participants with available ICD-9 data for mental health diagnoses, Center for Epidemiological Studies Depression (CES-D) measures, and self-reported adherence (SRA) were included. ART use was defined as ART initiation between 2006 and 2010, with follow-up through 2015. SRA was defined as taking 95% of ART doses and continuous ART was defined as longitudinal ART use with gaps < 30 days. Continuous VL suppression was defined as maintaining VLs < 200 c/mL on ART. To analyse the association between depression and HIV treatment outcomes, latent class analysis was used to create classes of depression trajectories: low depression (LD), recent onset depression (ROD) and high Depression (HD).
Participants had a mean age of 32 (± 8.3) years at HIV diagnosis, and similar proportions were Caucasian (44.3%) or African American (40.8%). Overall, older participants at HIV diagnosis had greater odds of having 95% self-reported adherence (OR 1.06, 95% CI 1.02-1.12), and African Americans had lower odds (OR 0.41, 95% CI 0.22-0.76) compared to Caucasians (OR 1.49, 95% CI 0.52-4.28). However, there was no difference in SRA by depression trajectory. Participants with HD had an increased odds of taking ART continuously (OR 1.75, 95% CI 0.99-3.09), and those with ROD had significantly higher odds of virologic failure (OR 0.58, 95% CI 0.38-0.91).
Although there was no observed association between depression and SRA, participants with ROD had lower odds of attaining the HIV treatment goal of VL suppression. Continued efforts to identify and aggressively manage mental health disorders is important to success along the HIV care continuum.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>33980262</pmid><doi>10.1186/s12981-021-00350-2</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1742-6405 |
| ispartof | AIDS research and therapy, 2021-05, Vol.18 (1), p.29-29, Article 29 |
| issn | 1742-6405 1742-6405 |
| language | eng |
| recordid | cdi_doaj_primary_oai_doaj_org_article_0ace82e1f04e42fcb4f46e36231ca2fe |
| source | Publicly Available Content Database; PubMed Central |
| subjects | Adherence African Americans Age AIDS/HIV Antiretroviral agents Antiretroviral therapy Care and treatment Clinical outcomes Demographics Depression Depression, Mental Diagnosis Epidemiology HIV HIV infection Human immunodeficiency virus Mental depression Mental disorders Mental health Minority & ethnic groups Psychological aspects Short Report Viral load suppression |
| title | Association between depression and HIV treatment outcomes in a US military population with HIV infection |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T02%3A48%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20between%20depression%20and%20HIV%20treatment%20outcomes%20in%20a%20US%20military%20population%20with%20HIV%20infection&rft.jtitle=AIDS%20research%20and%20therapy&rft.au=Carney,%20Brandon&rft.date=2021-05-12&rft.volume=18&rft.issue=1&rft.spage=29&rft.epage=29&rft.pages=29-29&rft.artnum=29&rft.issn=1742-6405&rft.eissn=1742-6405&rft_id=info:doi/10.1186/s12981-021-00350-2&rft_dat=%3Cgale_doaj_%3EA665429874%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c628t-b8bb96242e25f93540a6e9c182a6bef5e31efc8f4b568ebe28f361ab80119a3f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2528896816&rft_id=info:pmid/33980262&rft_galeid=A665429874&rfr_iscdi=true |